Get started
Author

Anne Kuijer

Observed names: A Kuijer, A. Kuijer, Kuijer A, Kuijer, A.
Observed institutions: European Organisation for Research and Treatment of Cancer, Brigham and Women's Hospital, Beth Israel Deaconess Medical Center, Université Libre de Bruxelles, Mayo Clinic, Harvard University, Utrecht University, Institut Jules Bordet, Institut Gustave Roussy, The Netherlands Cancer Institute, University Medical Center Utrecht, Massachusetts General Hospital, Bristol-Myers Squibb (United States), Rutgers Sexual and Reproductive Health and Rights, St. Antonius Ziekenhuis, Diakonessenhuis hospital, Dana-Farber Cancer Institute, European Organisation for Research and Treatment of Cancer, University of Colorado Cancer Center, Netherlands Comprehensive Cancer Organisation, Dana-Farber Brigham Cancer Center, UCSF Helen Diller Family Comprehensive Cancer Center, Stanford Cancer Institute, University of Twente, Stanford University
ORCID: 0000-0002-6666-1368
Observed ORCID: 0000-0002-6666-1368
OpenAlex ID: A5038426817
Trends on Axillary Surgery in Nondistant Metastatic Breast Cancer Patients Treated Between 2011 and 2015
2017 · Ingrid G. M. Poodt, Pauline E. R. Spronk, et al. · Annals of Surgery · 70
Impaired bone healing in multitrauma patients is associated with altered leukocyte kinetics after major trauma
2016 · Okan Bastian, Anne Kuijer, et al. · Journal of Inflammation Research · 47
PDF
Impact of 70-Gene Signature Use on Adjuvant Chemotherapy Decisions in Patients With Estrogen Receptor–Positive Early Breast Cancer: Results of a Prospective Cohort Study
2017 · Anne Kuijer, Marieke Straver, et al. · Journal of Clinical Oncology · 39
PDF
The influence of socioeconomic status and ethnicity on adjuvant systemic treatment guideline adherence for early-stage breast cancer in the Netherlands
2017 · A. Kuijer, J. Verloop, et al. · Annals of Oncology · 20
Assessment of tumour proliferation by use of the mitotic activity index, and Ki67 and phosphohistone H3 expression, in early‐stage luminal breast cancer
2020 · Julia E C van Steenhoven, Anne Kuijer, et al. · Histopathology · 19
PDF
Characterisation of multifocal breast cancer using the 70-gene signature in clinical low-risk patients enrolled in the EORTC 10041/BIG 03-04 MINDACT trial
2017 · K.C. Aalders, A. Kuijer, et al. · European Journal of Cancer · 17
Coronary artery bypass grafting in Takayasu’s disease – importance of the proximal anastomosis: a case report
2015 · Anne Kuijer, Matthijs F. M. van Oosterhout, et al. · Journal of Medical Case Reports · 17
PDF
Arm Morbidity After Local Therapy for Young Breast Cancer Patients
2021 · Anne Kuijer, Laura S. Dominici, et al. · Annals of Surgical Oncology · 16
Using a gene expression signature when controversy exists regarding the indication for adjuvant systemic treatment reduces the proportion of patients receiving adjuvant chemotherapy: a nationwide study
2015 · A. Kuijer, A.C.M. van Bommel, et al. · Genetics in Medicine · 15
PDF
Adjuvant systemic therapy in early breast cancer: impact of guideline changes and clinicopathological factors associated with nonadherence at a nation-wide level
2016 · A. M. F. Verschoor, A. Kuijer, et al. · Breast Cancer Research and Treatment · 13
The Changing Role of Gene-Expression Profiling in the Era of De-escalating Adjuvant Chemotherapy in Early-Stage Breast Cancer
2019 · J. E. C. van Steenhoven, A. Kuijer, et al. · Annals of Surgical Oncology · 11
PDF
Age, molecular subtypes and local therapy decision-making
2017 · Anne Kuijer, Tari A. King · The Breast · 11
Trends of Axillary Treatment in Sentinel Node-Positive Breast Cancer Patients Undergoing Mastectomy
2023 · Eline E. F. Verreck, Julia E. C. van Steenhoven, et al. · Annals of Surgical Oncology · 10
PDF
Changes over time in the impact of gene‐expression profiles on the administration of adjuvant chemotherapy in estrogen receptor positive early stage breast cancer patients: A nationwide study
2016 · A. Kuijer, C.A. Drukker, et al. · International Journal of Cancer · 10
PDF
Quantifying the Mitigating Effects of Whole-Breast Radiotherapy and Systemic Treatments on Regional Recurrence Incidence Among Breast Cancer Patients
2020 · Julia E. C. van Steenhoven, Anne Kuijer, et al. · Annals of Surgical Oncology · 7
PDF
Conventional Pathology Versus Gene Signatures for Assessing Luminal A and B Type Breast Cancers: Results of a Prospective Cohort Study
2018 · Julia E.C. Van Steenhoven, Anne Kuijer, et al. · Genes · 6
PDF
Impact of gene-expression profiling in patients with early breast cancer when applied outside the guideline directed indication area
2017 · K. Schreuder, A. Kuijer, et al. · European Journal of Cancer · 5
PDF
Factors Associated with the Use of Gene Expression Profiles in Estrogen Receptor-Positive Early-Stage Breast Cancer Patients: A Nationwide Study
2016 · Anne Kuijer, Kay Schreuder, et al. · Public Health Genomics · 5
Patients’ perceptions of 70-gene signature testing: commonly changing the initial inclination to undergo or forego chemotherapy and reducing decisional conflict
2020 · Julia E. C. van Steenhoven, Bianca M. den Dekker, et al. · Breast Cancer Research and Treatment · 4
PDF
The administration of adjuvant chemo(-immuno) therapy in the post ACOSOG-Z0011 era; a population based study
2018 · Ingrid G.M. Poodt, Marjolijn L. Rots, et al. · European Journal of Surgical Oncology · 4
Use and Impact of the 21-Gene Recurrence Score in Relation to the Clinical Risk of Developing Metastases in Early Breast Cancer Patients in the Netherlands
2018 · Kay Schreuder, Anne Kuijer, et al. · Public Health Genomics · 4
PDF
Short article
2015 · Anne Kuijer, Edgar J.B. Furnée, et al. · European Journal of Gastroenterology & Hepatology · 3
The Value of Ultrasound in Patients with T1–T2 Breast Cancer with No Palpable Lymph Nodes Enrolled in the EORTC 10981–22023 AMAROS Trial
2025 · A. W. J. Beerthuizen, T. I. M. Snellen, et al. · Annals of Surgical Oncology · 1
70-Gene signature-guided adjuvant systemic treatment adjustments in early-stage ER+ breast cancer patients: 7-year follow-up of a prospective multicenter cohort study
2024 · Eline E. F. Verreck, Anne Kuijer, et al. · Breast Cancer Research and Treatment · 1
PDF
Inequalities in the omission of axillary dissection in sentinel lymph node positive patients in the Netherlands: Innovative hospitals are early adopters of a de‐escalating approach
2022 · Julia E. C. van Steenhoven, Marissa C. van Maaren, et al. · International Journal of Cancer · 1
PDF
Works count: 44
Citation count: 359
H-index: 11
I10-index: 14
Year
Topic
Type